The notable points of these articles are not only the high diagnostic performance of 68 Ga-PSMA PET/CT but also possibly include 68 Ga-PSMA PET/CT for the initial staging of recurrent prostate cancer in the clinical algorithms. This evidence concerns the gene FOLH1 and prostate carcinoma.